-+ 0.00%
-+ 0.00%
-+ 0.00%

Takeda Reports 3.7% Revenue Decline at CER, 11.9% Core Operating Profit Drop in Q1 FY2025; VYVANSE Generic Erosion Hits Results

Reuters·07/30/2025 06:33:49

Please log in to view news